Literature DB >> 10095799

Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.

M Tidman1, R Olander, C Svalander, D Danielsson.   

Abstract

OBJECTIVES: To study organ involvement, anti-neutrophil cytoplasmic antibodies (ANCA) patterns, trends in yearly frequencies and seasonal variations of symptom onset in patients hospitalized because of small vessel vasculitides during a 21 year period (1975-95).
DESIGN: A retrospective investigation was conducted of 138 patients hospitalized with a diagnosis of small vessel vasculitides, as defined by the Chapel Hill Consensus Conference, within the County of Orebro, a mixed urban and rural area of central Sweden.
SETTING: Orebro Medical Center Hospital, Orebro, Sweden and two district hospitals within the County of Orebro, Sweden.
RESULTS: During the studied period there were 19 patients with a diagnosis of Wegener's granulomatosis (WG), 70 patients with microscopic polyangiitis (MPA), 36 patients with renal limited vasculitis (RLV), two with Churge-Strauss vasculitis (C-S), seven with Henoch-Schönleins purpura (HSP) and four with essential cryoglobulinemic vasculitis (ECV). Renal involvement was present in 123 patients (89.1%). A positive c- and/or pANCA was found in nearly 90% of the 111 patients where sera were available. Calculations of frequency data, restricted to the primary catchment area for patients with ANCA associated vasculitis and renal involvement (WG, MPA, RLV) during a 21-year period (1975-95) gave a mean annual frequency of 1.6 per 100,000 adults (95% CI: 1.2-3.1); for this group of patients with the inclusion of those with C-S, HSP and ECV during the last 10 year period (1986-95) gave a mean annual frequency of 2.5 per 100,000 adults (95% CI: 1.7-3.4), for male adults 3 per 100,000 (95% CI: 1.6-4.4), and female adults 1.9 (95% CI: 0.9-2.8). A frequency peak of 6.3 per 100,000 was seen for men aged 55-64. A periodic fluctuation of the frequencies with peaks every 3-4 years was noted for patients with ANCA related vasculitis (WG, MPA, RLV) during the 21-year period 1975-95. Onset of symptoms was predominantly noticed during the winter months (December-February) for patients with a positive cANCA.
CONCLUSION: The observed frequencies in our study of patients with small vessel vasculitides were higher than those previously documented. We also showed a periodic fluctuation of the annual frequencies and a seasonal variation of symptom onset.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10095799     DOI: 10.1046/j.1365-2796.1998.00324.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  17 in total

1.  Systemic vasculitis: epidemiology, classification and environmental factors.

Authors:  D G Scott; R A Watts
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

2.  Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.

Authors:  J M Clain; A M Hummel; J H Stone; F C Fervenza; G S Hoffman; C G M Kallenberg; C A Langford; W J McCune; P A Merkel; P A Monach; P Seo; R F Spiera; E W St Clair; S R Ytterberg; U Specks
Journal:  Clin Exp Immunol       Date:  2017-02-07       Impact factor: 4.330

3.  The expression of Toll-like receptors 2, 4 and 9 in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Authors:  H Wang; S-J Gou; M-H Zhao; M Chen
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 4.  Epidemiology of systemic vasculitis.

Authors:  Suzanne E Lane; Richard Watts; David G I Scott
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

5.  Intrarenal Toll-like receptor 4 and Toll-like receptor 2 expression correlates with injury in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Kim M O'Sullivan; Sharon L Ford; Anthony Longano; A Richard Kitching; Stephen R Holdsworth
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-20

Review 6.  Overview of the Pathogenesis of ANCA-Associated Vasculitis.

Authors:  Hong Xiao; Peiqi Hu; Ronald J Falk; J Charles Jennette
Journal:  Kidney Dis (Basel)       Date:  2015-12-03

7.  Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.

Authors:  Branka Bonaci-Nikolic; Sladjana Andrejevic; Milorad Pavlovic; Zoran Dimcic; Branislava Ivanovic; Milos Nikolic
Journal:  Clin Rheumatol       Date:  2010-03-20       Impact factor: 2.980

8.  The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis.

Authors:  Richard A Watts; Janice Mooney; Jane Skinner; David G I Scott; Alex J Macgregor
Journal:  Rheumatology (Oxford)       Date:  2012-01-17       Impact factor: 7.580

9.  Stable incidence of systemic vasculitides in schleswig-holstein, Germany.

Authors:  Karen Herlyn; Bernhard Hellmich; Wolfgang L Gross; Eva Reinhold-Keller
Journal:  Dtsch Arztebl Int       Date:  2008-05-09       Impact factor: 5.594

Review 10.  Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan.

Authors:  Kensuke Joh; Eri Muso; Hidekazu Shigematsu; Masato Nose; Michio Nagata; Yoshihiro Arimura; Wako Yumura; Takashi Wada; Kousaku Nitta; Hirofumi Makino; Yoshio Taguma; Hidetoshi Kaneoka; Yuhsuke Suzuki; Masaki Kobayashi; Akio Koyama; Joichi Usui; Hiroshi Hashimoto; Shoichi Ozaki; Yasuhiko Tomino; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2008-04-22       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.